[HTML][HTML] Subcutaneous progesterone is effective and safe for luteal phase support in IVF: an individual patient data meta-analysis of the phase III trials
J Doblinger, B Cometti, S Trevisan, G Griesinger - PLoS One, 2016 - journals.plos.org
Objective To summarize efficacy and safety data on a new progesterone compound which is
available for subcutaneous administration as compared to vaginally administered …
available for subcutaneous administration as compared to vaginally administered …
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
J Doblinger, B Cometti, S Trevisan, G Griesinger - PLOS ONE, 2016 - econpapers.repec.org
Objective: To summarize efficacy and safety data on a new progesterone compound which
is available for subcutaneous administration as compared to vaginally administered …
is available for subcutaneous administration as compared to vaginally administered …
[PDF][PDF] Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
J Doblinger, B Cometti, S Trevisan… - PLoS ONE, 2016 - pdfs.semanticscholar.org
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual
Patient Data Meta-Analysis of the Page 1 RESEARCH ARTICLE Subcutaneous Progesterone …
Patient Data Meta-Analysis of the Page 1 RESEARCH ARTICLE Subcutaneous Progesterone …
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
J Doblinger, B Cometti, S Trevisan… - PloS one, 2016 - pubmed.ncbi.nlm.nih.gov
Objective To summarize efficacy and safety data on a new progesterone compound which is
available for subcutaneous administration as compared to vaginally administered …
available for subcutaneous administration as compared to vaginally administered …
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials.
J Doblinger, B Cometti, S Trevisan, G Griesinger - Plos one, 2016 - europepmc.org
Objective To summarize efficacy and safety data on a new progesterone compound which is
available for subcutaneous administration as compared to vaginally administered …
available for subcutaneous administration as compared to vaginally administered …
[PDF][PDF] Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
J Doblinger, B Cometti, S Trevisan, G Griesinger - PLoS ONE, 2016 - researchgate.net
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual
Patient Data Meta-Analysis of the Page 1 RESEARCH ARTICLE Subcutaneous Progesterone …
Patient Data Meta-Analysis of the Page 1 RESEARCH ARTICLE Subcutaneous Progesterone …
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
J Doblinger, B Cometti, S Trevisan… - PLoS ONE, 2016 - research.uni-luebeck.de
OBJECTIVE: To summarize efficacy and safety data on a new progesterone compound
which is available for subcutaneous administration as compared to vaginally administered …
which is available for subcutaneous administration as compared to vaginally administered …
[引用][C] Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials.
J Doblinger, B Cometti, S Trevisan, G Griesinger - PLOS ONE, 2016 - pure.pmu.ac.at
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual
Patient Data Meta-Analysis of the Phase III Trials. — PMU Research Portal Skip to main …
Patient Data Meta-Analysis of the Phase III Trials. — PMU Research Portal Skip to main …
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
J Doblinger, B Cometti, S Trevisan, G Griesinger - PLOS ONE, 2016 - ideas.repec.org
Objective: To summarize efficacy and safety data on a new progesterone compound which
is available for subcutaneous administration as compared to vaginally administered …
is available for subcutaneous administration as compared to vaginally administered …
[引用][C] Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
J Doblinger, B Cometti, S Trevisan… - PLoS ONE, 2016 - ui.adsabs.harvard.edu
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An
Individual Patient Data Meta-Analysis of the Phase III Trials - NASA/ADS Now on home …
Individual Patient Data Meta-Analysis of the Phase III Trials - NASA/ADS Now on home …